DUBLIN--(BUSINESS WIRE)--The "Global Circulating Tumor Cells (CTC) Market - Segmented by Technology, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
Growing Prevalence of Cancer
The growing prevalence of cancer patients has a direct impact on increased demand for CTC market. Thus, the increasing prevalence of different types of cancers directly benefits the growth of CTC market.
Other driving factors for this market include the development of cluster chip technology for capturing clusters of CTCs, advancements in biomedical imaging and bioengineering technology and increasing demand for preventive medicine and companion diagnostics.
- Technical Difficulties in Detection and Characterization of CTCs
- Asia Pacific to Witness the Fastest Growth Rate
Key Developments in the Market
- Natera, a company involved in non-invasive genetic testing and the analysis of circulating cell-free DNA, to present successful results of Signatera, to monitor colorectal cancer and identify disease recurrence.
- Biocept Inc received patent for its Target Selector assays for molecular analysis to improve the patient diagnosis with cancer in China.
- Advanced Cell Diagnostics Inc.
- ApoCell
- Aviva Biosciences
- Biocept Inc.
- Cynvenio Biosystems Inc.
- Clearbridge Biomedics Pte Ltd.
- Creatv Microtech Inc.
- Menarini Silicon Biosystems
- Miltenyi Biotec
- Qiagenn
Key Topics Covered
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Market Dynamics
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future Market Outlook
For more information about this report visit https://www.researchandmarkets.com/research/mftrsq/global?w=4